These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 14717973
21. Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue. Larsen OH, Clausen N, Persson E, Ezban M, Ingerslev J, Sørensen B. Br J Haematol; 2009 Jan; 144(1):99-106. PubMed ID: 19016728 [Abstract] [Full Text] [Related]
22. Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro. Minami H, Nogami K, Yada K, Ogiwara K, Furukawa S, Soeda T, Kitazawa T, Shima M. J Thromb Haemost; 2019 Jan; 17(1):126-137. PubMed ID: 30444568 [Abstract] [Full Text] [Related]
23. Potential role of recombinant factor VIIa as a hemostatic agent. Hedner U, Erhardtsen E. Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390 [Abstract] [Full Text] [Related]
31. Thrombin generation potential in the presence of concizumab and rFVIIa, APCC, rFVIII, or rFIX: In vitro and ex vivo analyses. Kjalke M, Kjelgaard-Hansen M, Andersen S, Hilden I. J Thromb Haemost; 2021 Jul; 19(7):1687-1696. PubMed ID: 33819375 [Abstract] [Full Text] [Related]
33. Recombinant factor VIIa enhances platelet deposition from flowing haemophilic blood but requires the contact pathway to promote fibrin deposition. Li R, Panckeri KA, Fogarty PF, Diamond SL. Haemophilia; 2015 Mar; 21(2):266-274. PubMed ID: 25311576 [Abstract] [Full Text] [Related]
36. Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A. Lisman T, Mosnier LO, Lambert T, Mauser-Bunschoten EP, Meijers JC, Nieuwenhuis HK, de Groot PG. Blood; 2002 Jan 01; 99(1):175-9. PubMed ID: 11756168 [Abstract] [Full Text] [Related]
37. General haemostatic agents--fact or fiction? Hedner U. Pathophysiol Haemost Thromb; 2002 Jan 01; 32 Suppl 1():33-6. PubMed ID: 12214145 [Abstract] [Full Text] [Related]
38. Variants of recombinant factor VIIa with increased intrinsic activity. Persson E. Semin Hematol; 2004 Jan 01; 41(1 Suppl 1):89-92. PubMed ID: 14872428 [Abstract] [Full Text] [Related]
39. Prohemostatic Activity of Factor X in Combination With Activated Factor VII in Dilutional Coagulopathy. Takeshita S, Ogawa S, Nakayama Y, Mukai N, Nakajima Y, Mizobe T, Sawa T, Tanaka KA. Anesth Analg; 2019 Aug 01; 129(2):339-345. PubMed ID: 30320649 [Abstract] [Full Text] [Related]
40. Effects of recombinant human prothrombin on thrombin generation in plasma from patients with hemophilia A and B. Hansson KM, Gustafsson D, Skärby T, Frison L, Berntorp E. J Thromb Haemost; 2015 Jul 01; 13(7):1293-300. PubMed ID: 25944555 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]